My Portfolio

Novo Nordisk A/S NOV1-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR

Last | 3:25 PM CEST

10.60

-0.30 (-2.75%)

52 week range

8.85 - 16.20

Open10.60
Day High10.60
Day Low10.60
Prev Close12.20
52 Week High16.20
52 Week High Date01/19/26
52 Week Low8.85
52 Week Low Date03/02/26

Latest On Novo Nordisk A/S

No one has a weight loss drug in the pipeline that's in the same league as Eli Lilly's, says Jim Cramer2 Hours AgoCNBC.com
Health insurer Cigna will stop covering GLP-1 weight loss drugs in its employee health plan14 Hours AgoCNBC.com
Wegovy weight loss pill launches in the UAE as Novo looks beyond the U.S. market18 Hours AgoCNBC.com
Jim Cramer looks at stocks that will go higher if tech retreatsJune 2, 2026CNBC.com
Here are JPMorgan's favorite stocks heading into JuneJune 2, 2026CNBC.com
Thursday, May 28, 2026: Cramer says it's worth it to stay long this software giantMay 28, 2026CNBC.com
CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plansMay 28, 2026CNBC.com
Here’s our monthly update on all 33 portfolio stocks, including 4 to buy right nowMay 27, 2026CNBC.com
Signos grows foothold in weight-loss wave fueled by GLP-1s with AI trackingMay 27, 2026CNBC.com
BMO's Evan Seigerman on GLP-1 developments, state of weight-loss drug battleMay 27, 2026CNBC.com

Key Stats

Market Cap-
Shares Out-
10 Day Average Volume-
Dividend0.32
Dividend Yield3.02%
Beta-

Latest On Novo Nordisk A/S

No one has a weight loss drug in the pipeline that's in the same league as Eli Lilly's, says Jim Cramer2 Hours AgoCNBC.com
Health insurer Cigna will stop covering GLP-1 weight loss drugs in its employee health plan14 Hours AgoCNBC.com
Wegovy weight loss pill launches in the UAE as Novo looks beyond the U.S. market18 Hours AgoCNBC.com
Jim Cramer looks at stocks that will go higher if tech retreatsJune 2, 2026CNBC.com
Here are JPMorgan's favorite stocks heading into JuneJune 2, 2026CNBC.com
Thursday, May 28, 2026: Cramer says it's worth it to stay long this software giantMay 28, 2026CNBC.com
CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plansMay 28, 2026CNBC.com
Here’s our monthly update on all 33 portfolio stocks, including 4 to buy right nowMay 27, 2026CNBC.com
Signos grows foothold in weight-loss wave fueled by GLP-1s with AI trackingMay 27, 2026CNBC.com
BMO's Evan Seigerman on GLP-1 developments, state of weight-loss drug battleMay 27, 2026CNBC.com

KEY STATS

Open10.60
Day High10.60
Day Low10.60
Prev Close12.20
52 Week High16.20
52 Week High Date01/19/26
52 Week Low8.85
52 Week Low Date03/02/26
Market Cap-
Shares Out-
10 Day Average Volume-
Dividend0.32
Dividend Yield3.02%
Beta-

RATIOS/PROFITABILITY

EPS (TTM)-
P/E (TTM)-
Fwd P/E (NTM)-
EBITDA (TTM)-
ROE (TTM)-
Revenue (TTM)-
Gross Margin (TTM)-
Net Margin (TTM)-
Debt To Equity (MRQ)-

EVENTS

Earnings Date-
Ex Div Date03/30/2026
Div Amount0.5167
Split Date-
Split Factor-

Content From Our Affiliates

ASML Stock Crushes European Records as JPMorgan Analyst Warns Investors Are “Behind the Curve”10 Hours AgoTipRanks
Goldman Sachs Sticks to Its Hold Rating for Novo Nordisk (NVO)14 Hours AgoTipRanks
Moderately bullish activity in Novo Nordisk with shares down 2.99%June 1, 2026TipRanks
Entera Bio Is Building the Future of Peptides Beyond the Needle (NASDAQ: ENTX)June 1, 2026TipRanks
Novo Nordisk Details Progress of 2026 Share Buyback ProgrammeJune 1, 2026TipRanks

Profile

Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral...

Lars Rebien Soerensen

Non-Executive Chairman of the Board

Maziar Doustdar

President, Chief Executive Officer

Karsten Munk Knudsen

Chief Financial Officer, Executive Vice President

Ludovic Helfgott

Executive Vice President - Product and Portfolio Strategy

Emil Larsen

Executive Vice President - International Operations

Address

Novo Alle 1

Bagsvaerd

2880

Denmark

https://www.novonordisk.com/